Symptom control in terminally ill patients with malignant bowel obstruction (MBO)
Open Access
- 31 January 1994
- journal article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 9 (1) , 12-18
- https://doi.org/10.1016/0885-3924(94)90141-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patientsJournal of Pain and Symptom Management, 1992
- Intestinal obstruction in patients with widespread intraabdominal malignancyJournal of Pain and Symptom Management, 1992
- Treatment of diarrhoea due to enterocolic fistula with octreotide in a terminal cancer patientPalliative Medicine, 1992
- Percutaneous endoscopic gastrostomy.BMJ, 1992
- Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?BMJ, 1991
- Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstructionJournal of Pain and Symptom Management, 1991
- The Edmonton injector: A simple device for patient-controlled subcutaneous analgesiaPain, 1991
- The use of corticosteroids for symptom management in terminally ill patientsAmerican Journal of Hospice Care, 1990
- Nutrition in cancer patients: an update and review of our experienceJournal of Pain and Symptom Management, 1988
- Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.BMJ, 1984